Incyte (INCY) Revenue Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3,790.58% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 20.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.87% |
| Dec 31, 2025 | 27.84% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 16.46% |
| Mar 31, 2025 | 19.53% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 23.81% |
| Jun 30, 2024 | 9.34% |
| Mar 31, 2024 | 8.93% |
| Dec 31, 2023 | 9.35% |
| Sep 30, 2023 | 11.63% |
| Jun 30, 2023 | 4.74% |
| Mar 31, 2023 | 10.29% |
| Dec 31, 2022 | 7.40% |
| Sep 30, 2022 | 1.27% |
| Jun 30, 2022 | 29.15% |
| Mar 31, 2022 | 21.25% |
| Dec 31, 2021 | 9.29% |
| Sep 30, 2021 | 30.99% |
| Jun 30, 2021 | 2.57% |
| Mar 31, 2021 | 6.37% |
| Dec 31, 2020 | 36.27% |
| Sep 30, 2020 | 12.52% |
| Jun 30, 2020 | 29.84% |
| Mar 31, 2020 | 14.19% |
| Dec 31, 2019 | 9.65% |
| Sep 30, 2019 | 22.66% |
| Jun 30, 2019 | 1.61% |
| Mar 31, 2019 | 30.23% |
| Dec 31, 2018 | 18.97% |
| Sep 30, 2018 | 17.86% |
| Jun 30, 2018 | 59.76% |
| Mar 31, 2018 | -0.47% |
| Dec 31, 2017 | 36.04% |
| Sep 30, 2017 | 41.59% |
| Jun 30, 2017 | 32.55% |
| Mar 31, 2017 | 45.78% |
| Dec 31, 2016 | 33.88% |
| Sep 30, 2016 | 43.63% |
| Jun 30, 2016 | 51.11% |
| Mar 31, 2016 | 65.41% |
| Dec 31, 2015 | 96.72% |
| Sep 30, 2015 | -5.32% |
| Jun 30, 2015 | 63.67% |
| Mar 31, 2015 | 77.38% |
| Dec 31, 2014 | 27.71% |
| Sep 30, 2014 | 132.78% |
| Jun 30, 2014 | -2.06% |
| Mar 31, 2014 | 26.33% |
| Dec 31, 2013 | -14.73% |
| Sep 30, 2013 | 40.72% |
| Jun 30, 2013 | 17.49% |
| Mar 31, 2013 | 96.46% |
| Dec 31, 2012 | 294.08% |
| Sep 30, 2012 | 260.46% |
| Jun 30, 2012 | 414.79% |
| Mar 31, 2012 | 13.15% |
| Dec 31, 2011 | -66.36% |
| Sep 30, 2011 | -0.53% |
| Jun 30, 2011 | -66.27% |
| Mar 31, 2011 | 84.94% |